Stefan Höfmann

6PUBLICATIONS
33CO-AUTHORS
Biomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesPharmacogenomicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 06, 2026
Reverse Fosmidomycin Analogs as Bisubstrate Inhibitors: Binding Mode Elucidation and Mechanistic Insights.

|Jan 15, 2025
Expanding the Chemical Space of Reverse Fosmidomycin Analogs.

Talea Knak, Sana Takada, Boris Illarionov

|Jan 11, 2025
The Diverse Binding Modes Explain the Nanomolar Levels of Inhibitory Activities Against 1-Deoxy-d-Xylulose 5-Phosphate Reductoisomerase from Plasmodium falciparum Exhibited by Reverse Hydroxamate Analogs of Fosmidomycin with Varying N-Substituents.

Sana Takada, Mona A Abdullaziz, Stefan Höfmann

|Apr 22, 2024
Reverse N-Substituted Hydroxamic Acid Derivatives of Fosmidomycin Target a Previously Unknown Subpocket of 1-Deoxy-d-xylulose 5-Phosphate Reductoisomerase (DXR).

Mona A Abdullaziz, Sana Takada, Boris Illarionov

|Dec 23, 2022
Over 40 Years of Fosmidomycin Drug Research: A Comprehensive Review and Future Opportunities.

Talea Knak, Mona A Abdullaziz, Stefan Höfmann

|Aug 24, 2022
Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies.

Aaron Burmeister, Alexa Stephan, Leandro A Alves Avelar

Pageof 1

Frequent Collaborators

6 joint publications

Thomas Kurz

5 joint publications

Nobutada Tanaka

4 joint publications

Sana Takada

2 joint publications

Jana Held